magNews

Corporate Industry Technology Medical Updates

Redefining New Boundaries in Delivering Patient Care

magAssist Recognized in 2024 VENTURE50 Awards

MoyoAssist® Extra-VAD® Introduces Fully Magnetically Levitated Extracorporeal Heart Support Technology in China

MoyoAssist® Launched! The Mid-to-Short-Term MCS Forum and Extra-VAD Clinical Technology Transformation Results Conference Successfully Held

Corporate
FDA Grants "Breakthrough Device" Designation to magAssist's NyokAssist® Interventional Ventricular Assist Device 2023-08-17
Corporate
The Cross-Strait Youth Cultural Month Kicks off, as magAssist Engages in a Dialogue with Taiwanese Youth 2023-07-28
Corporate
BreathMo®: The New Generation ECMO system Revealed at ASAIO Conference 2023-07-22
Corporate
MoyoAssist® Extra-VAD, a Promising Solution for Short-to-Medium-Term Ventricular Assist for China NMPA trial, Showcased at 4th Academic Annual Conference of CSBE 2023-06-17
Corporate
Embarking on an Innovation Journey with Students from Duke Kunshan University 2023-06-13
Corporate
magAssist Among Exclusive 17 Selected Enterprises in Suzhou 2023-05-29
Corporate
magAssist Once Again Named in 2023 Future Healthcare VB100 List- China Innovative Medical Devices List 2023-05-09
Corporate
magAssist Made it into the Second KPMG China Biotechnology Enterprises Top 50 List 2023-04-11
Corporate
The Chinese Start-Up Advancing Life Support Tech 2023-03-30
Corporate
magAssist Revealed in MedTech Outlook's Top 10 MedTech Companies in APAC Region for 2022 2023-03-14

Tags： Innovation, Application, Extra-VAD, U.S. FDA, Interventional Ventricular Assist Device, Breakthrough Device, VENTURE50, Awards, Healthcare, Difference,